Detalhe da pesquisa
1.
The predictive value of the modified AFP model for liver transplantation outcomes in multinodular hepatocellular carcinoma patients.
World J Surg Oncol
; 21(1): 104, 2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967432
2.
E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation.
Am J Transplant
; 22(10): 2323-2336, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729702
3.
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Gut
; 69(7): 1322-1334, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776228
4.
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Hepatobiliary Pancreat Dis Int
; 19(4): 349-357, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622826
5.
mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma.
Mol Biomed
; 5(1): 9, 2024 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461206
6.
Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma.
MedComm (2020)
; 4(6): e439, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045832
7.
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
J Immunother Cancer
; 11(11)2023 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030304
8.
Downstaging treatment for patients with hepatocelluar carcinoma before transplantation.
Transplant Rev (Orlando)
; 35(2): 100606, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33636480
9.
Sirolimus-based immunosuppression improves the prognosis of liver Transplantation Recipients with low TSC1/2 expression in hepatocellular carcinoma beyond the Milan Criteria.
Eur J Surg Oncol
; 47(10): 2533-2542, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902956
10.
Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy.
Adv Sci (Weinh)
; 8(5): 2003042, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717848
11.
Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria.
Ann Transl Med
; 8(4): 80, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32175373